Oncomfort

 Digital Sedation for relieving patients’ pain and anxiety using digital therapy
(combines clinical hypnotherapy and integrative therapeutic techniques) in virtual
reality.
 Raised €10M Series A investment in 2020 with a Series B likely.
 The CEO stated that they have plans to raise its next round of capital
in early 2023 to support entry into the US market.
 Will look to raise between EUR 30m (US 35.5m) and EUR 50m (USD
59.2m) in early 2023.
 Megatrend of mental health (anxiety) support.
o People are often fearful of drug-based treatments - this has the possibility to
help with that or remove the need for drug-based resolutions. altogether for
some individuals.
 Has the possibility of both B2C and B2B illustrating potential huge whitespace.
o It is not a winner takes all market - plenty of whitespace.
 Has proven benefits - reducing surgery time by 10% to 15% and increasing recovery
speed by 50%

Prolific
 Marketplace that connects researchers with research participants, enabling hundreds of
thousands of surveys, research studies, and AI/ML training tasks
 What is interesting – extremely strong client base for a business of this size – illustrates its
proven business model - Clients - Google, Meta, McKinsey, Snap, Harvard, Penn, Yale, UCL,
Oxford
 TAM - $90B+ global market research services market
 Leadership team seems to be very well experienced in the research industry
 I sadly do not have many metrics – but through linkedin – the company seems FTES seem to
be growing rpidly 50% in past 2 years
 Its specific product of AI research is particularly interesting at the moment with what is
occurring in that area at the moment – everyone wants a piece of the AI Pie and likely to
grow further in the coming years
 A concern or question I have is what are they doing different – how are they going to kep
their cohort of researchers